Expanding diagnostic criteria and reduced stigma may be capturing individuals with less severe genetic predispositions to neurodevelopmental conditions, fundamentally altering the patient populations being identified. This shift has profound implications for how clinicians interpret genetic risk scores and tailor treatment approaches across different generations of diagnoses.
Analyzing over two decades of Danish population data from 1994 to 2016, researchers tracked polygenic risk scores across multiple psychiatric and cognitive domains in individuals receiving first-time ADHD and autism spectrum disorder diagnoses. The investigation revealed a consistent downward trend in genetic risk burden among more recently diagnosed individuals, suggesting that broadened awareness and diagnostic accessibility are identifying cases with milder genetic vulnerability profiles compared to earlier cohorts.
This pattern represents a significant methodological challenge for psychiatric genetics research, where foundational studies often relied on more severely affected historical cohorts. The findings suggest that genetic risk prediction models calibrated on earlier diagnostic populations may overestimate hereditary contributions in contemporary clinical settings. For families navigating neurodevelopmental diagnoses, this research indicates that recent diagnoses may carry different prognostic implications than suggested by studies based on older, more genetically homogeneous patient groups. The trend also validates clinical observations that today's diagnostic landscape captures a broader spectrum of presentations, though it complicates efforts to establish consistent genetic counseling frameworks across different diagnostic eras.